Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC

Aleksandar Sekulic*, Michael R. Migden, Karl Lewis, John D. Hainsworth, James A. Solomon, Simon Yoo, Sarah T. Arron, Philip A. Friedlander, Ellen Marmur, Charles M. Rudin, Anne Lynn S. Chang, Luc Dirix, Jeannie Hou, Huibin Yue, Axel Hauschild

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

147 Scopus citations

Fingerprint

Dive into the research topics of 'Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC'. Together they form a unique fingerprint.

Medicine & Life Sciences